Mansour-Ghanaei Fariborz, Fallah Mohammad S, Shafaghi Afshin, Yousefi-Mashhoor Mahmood, Ramezani Naghi, Farzaneh Farshid, Nassiri Reza
Gastrointestinal & Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.
Med Sci Monit. 2002 Dec;8(12):CR797-800.
The aim of this study was to determine the seroprevalence of hepatitis B and C viruses and abnormal liver function tests among hemophiliacs in Guilan province, Iran.
MATERIAL/METHODS: Patients registered with Guilan Hemophilia Society (GHS) were enrolled in this study, and evaluated for the presence of hepatitis B surface antigen (HBsAg), hepatitis C virus antibody (HCV-Ab) and liver function tests.
One hundred and one patients (100 males, 1 female, mean age 19.7 years, range 3-71 years) from 110 registered hemophiliacs were enrolled in this study. 29 patients (28.7%) had elevated Alanine aminotransferase (ALT), 27 (26.7%) and 72 (71.3%) were positive for HBsAg and HCV-Ab, respectively. Seropositivity for HCV-Ab correlated with the duration of treatment with clotting factor until 1997 (P=0.01). There was also an inverse correlation between factor VIII & IX activity and seropositivity for HCV-Ab (P<0.001) and HBsAg (P<0.04). HCV-Ab was more likely to be positive among those received lyophilized factor VIII and cryoprecipitate than lyophilized factor VIII alone (P<0.01). In addition HCV-Ab seropositivity was more common among those received factor IX concentrate and fresh frozen plasma (FFP) than those received only FFP (P<0.01).
Based upon our finding, prevalence of HBsAg positive cases in Guilan province was higher than other studies. Although frequency of HCV-Ab was similar to other studies, frequency of increased ALT was less. Upon the results emerged from this study, we recommend that all hemophiliacs should be vaccinated against HBV and should have regular program for checking HCV.
本研究旨在确定伊朗吉兰省血友病患者中乙型和丙型肝炎病毒的血清流行率以及肝功能检查异常情况。
材料/方法:纳入吉兰血友病协会(GHS)登记的患者,评估其乙型肝炎表面抗原(HBsAg)、丙型肝炎病毒抗体(HCV-Ab)及肝功能检查情况。
本研究纳入了110名登记血友病患者中的101例(100名男性,1名女性,平均年龄19.7岁,范围3 - 71岁)。29例患者(28.7%)丙氨酸氨基转移酶(ALT)升高,27例(26.7%)HBsAg阳性,72例(71.3%)HCV-Ab阳性。1997年前HCV-Ab血清阳性与凝血因子治疗持续时间相关(P = 0.01)。VIII因子和IX因子活性与HCV-Ab血清阳性(P < 0.001)及HBsAg血清阳性(P < 0.04)呈负相关。接受冻干VIII因子和冷沉淀的患者中HCV-Ab阳性的可能性高于仅接受冻干VIII因子的患者(P < 0.01)。此外,接受IX因子浓缩物和新鲜冰冻血浆(FFP)的患者中HCV-Ab血清阳性比仅接受FFP的患者更常见(P < 0.01)。
基于我们的研究结果,吉兰省HBsAg阳性病例的患病率高于其他研究。虽然HCV-Ab的频率与其他研究相似,但ALT升高的频率较低。根据本研究结果,我们建议所有血友病患者应接种乙肝疫苗,并应制定定期检查丙肝的计划。